CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health pharmacy & Consumer Wellness — Cost of Products Sold ($M)
Annual figures from Cvs Health's filings and investor materials
Latest, FY2025
113,583
Period ended Dec 31, 2025
Change on a year earlier
+14.3%
99,337 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmacy & Consumer Wellness — Cost of Products Sold ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 113,583 | +14.3% | CVS Health 10-K (2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 99,337 | +8.6% | CVS Health 10-K (2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 91,447 | +11.4% | CVS Health 10-K (2026-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 82,063 | +9.3% | CVS Health 10-K (2025-02-12) ↗ |
| FY2021 | Dec 31, 2021 | 75,082 | +11.6% | CVS Health 10-K (2024-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 67,284 | +7.3% | CVS Health 10-K (2023-02-08) ↗ |
| FY2019 | Dec 31, 2019 | 62,688 | +4.6% | CVS Health 10-K (2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 59,906 | +6.8% | CVS Health 10-K (2021-02-16) ↗ |
| FY2017 | Dec 31, 2017 | 56,066 | – | CVS Health 10-K (2020-02-18) ↗ |
Cite this data
StockData. (2026). Cvs Health Pharmacy & Consumer Wellness — Cost of Products Sold ($M), annual FY2017–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw_cost_products
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.